VitaNova Life Sciences Corp (VNOV) Financial Statements (2026 and earlier)

Company Profile

Business Address 39 E. BROADWAY, STE 603
NEW YORK, NY 10002
State of Incorp. NV
Fiscal Year End April 30
Industry (SIC) 513 - Apparel, Piece Goods, And Notions (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

1/31/2026
MRQ
4/30/2025
4/30/2024
4/30/2023
4/30/2022
4/30/2021
4/30/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments783593923  
Cash and cash equivalent783593923  
Receivables1,426461    
Inventory, net of allowances, customer advances and progress billings44133    
Inventory44133    
Other current assets36    
Total current assets:2,2561,193923  
Noncurrent Assets
TOTAL ASSETS:2,2561,193923  
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:6061  2919
Accounts payable      
Accrued liabilities28765  2919
Other undisclosed accounts payable and accrued liabilities (227)(4)    
Other liabilities 18    
Due to related parties✕✕✕ 12146104
Other undisclosed current liabilities287686846  
Total current liabilities:3481376858175123
Noncurrent Liabilities
Total liabilities:3481376858175123
Equity
Equity, attributable to parent, including:1,9091,056(59)(35)(175)(123)
Common stock25256666
Additional paid in capital1,0131,01359595959
Retained earnings (accumulated deficit)86817(124)(100)(239)(187)
Other undisclosed equity, attributable to parent31    
Total equity:1,9091,056(59)(35)(175)(123)
TOTAL LIABILITIES AND EQUITY:2,2561,193923  

Income Statement (P&L) ($ in thousands)

1/31/2026
TTM
4/30/2025
4/30/2024
4/30/2023
4/30/2022
4/30/2021
4/30/2020
Revenues2,66257138120  
Cost of revenue(1,086)(193)    
Gross profit:1,57637838120  
Operating expenses(367)(172)(62)(133)(52)(72)
Operating income (loss):1,208206(24)(13)(52)(72)
Nonoperating income (expense)(4)0    
Other nonoperating income00    
Interest and debt expense(5)     
Income (loss) from continuing operations before equity method investments, income taxes:1,200206(24)(13)(52)(72)
Other undisclosed income from continuing operations before income taxes5  153  
Income (loss) from continuing operations before income taxes:1,204206(24)140(52)(72)
Income tax expense(354)(65)    
Income (loss) from continuing operations:851141(24)140(52)(72)
Income (loss) before gain (loss) on sale of properties:✕✕✕✕140(52)(72)
Net income (loss) available to common stockholders, diluted:851141(24)140(52)(72)

Comprehensive Income ($ in thousands)

1/31/2026
TTM
4/30/2025
4/30/2024
4/30/2023
4/30/2022
4/30/2021
4/30/2020
Net income (loss):851141(24)140(52)(72)
Comprehensive income (loss), net of tax, attributable to parent:851141(24)140(52)(72)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: